Abstract: Unmanned aerial vehicles are increasingly offering several benefits to society. The series of functional characteristics for these actions justify this importance. However, such systems ...

After your third week, a Factor prepared-meal subscription comes with a Withings Body Comp scale that scans your body-fat percentage. Lord help me. I will admit to being afraid of scales—the kind that ...

Death, taxes, and stressing about what you're going to eat for lunch tomorrow—three of the universally dreaded (but inevitable) certainties in life, right? Well, not exactly. Whether you're a meal ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. If 2025 will be known for anything in the bike industry, it ought to be the proliferation of ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...

"Fear Factor" is returning to screens, and it’s looking very different from the last time you saw it. Officially called "Fear Factor: The Next Chapter", the extreme competition series is adding a ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...